(or "the Company")
PDMR Dealing
Following this transaction, Paul is interested in 511,628 Ordinary Shares representing 0.84% of the issued share capital of the Company.
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation as it forms part of
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
|
|
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a) |
|
|
||||
|
2 |
Reason for the notification |
|||||
|
a) |
Position/status |
PDMR, Chief Financial Officer |
||||
|
b)
|
Initial notification /Amendment |
Initial notification |
||||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
|
|
||||
|
b) |
LEI |
213800G2F8I1N7HTVP88 |
||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a)
|
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of
ISIN: GB00BYX1P358 |
||||
|
b) |
Nature of the transaction |
Sale of Ordinary Shares |
||||
|
c) |
Price(s) and volume(s) |
Sale of Ordinary Shares
|
||||
|
d) |
Aggregated information - Aggregated volume - Price |
As above
|
||||
|
e) |
Date of the transaction |
|
||||
|
f) |
Place of the transaction |
Outside a trading venue |
||||
For further information please contact:
|
|
+44 (0) 161 486 3441 |
|||||
|
Zeus - Nomad and Broker
|
+44 (0) 20 3829 5000 |
|||||
|
+44 (0) 20 7496 3000 |
|||||
|
|
+44 (0) 20 7653 4000 |
|||||
|
|
+44 (0) 20 4582 3500 |
|||||
|
Trade Media Enquiries |
+44 (0) 7469 854 011 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the